Related Experiment Video

Updated: Oct 6, 2026

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

[Formation of neutralizing antibodies in therapy of multiple sclerosis with interferon beta-1b. Practical procedure

E U Walther1, T Dang, H P Hartung

  • 1Neurologische Klinik und Poliklinik, Klinikum Grosshadern, Ludwig-Maximilians-Universität, München.

Der Nervenarzt
|February 18, 1998
PubMed

Insights

Neutralizing antibodies can reduce interferon beta-1b efficacy in multiple sclerosis (MS) patients. Antibody testing is recommended if treatment failure is suspected to ensure therapeutic benefit.

Area of Science:

  • Neuroimmunology
  • Pharmacology

Context:

  • Interferon beta-1b is a key treatment for relapsing-remitting multiple sclerosis (MS).
  • A significant percentage of patients develop neutralizing antibodies against interferon beta-1b.
  • These antibodies can diminish the drug's effectiveness.

Purpose:

  • To provide guidelines for testing neutralizing antibodies against interferon beta-1b.
  • To address the issue of treatment failure in MS patients due to antibody development.

Summary:

  • Neutralizing antibodies were developed in approximately 35% of patients in a North American study of interferon beta-1b.
  • Antibody-negative patients experienced a 50% reduction in annual relapse rate compared to placebo.
  • Guidelines for neutralizing antibody testing are presented for suspected treatment failure.

Impact:

  • Facilitates appropriate patient management in multiple sclerosis.
  • Aids clinicians in identifying treatment efficacy issues related to antibody formation.
  • Supports personalized therapeutic strategies for MS patients receiving interferon beta-1b.

More Related Videos

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay07:52

Detection of Antibodies That Neutralize the Cellular Uptake of Enzyme Replacement Therapies with a Cell-based Assay

Published on: September 10, 2018

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...